Showing 1 - 4 results of 4 for search 'Arif Abdillah' Skip to content
    • About the Library
    • Rules and Regulations
    • Library Services
    • Library Hours
  • Library News
    • Digital Repository
    • Google Scholar
    • ResearchGate
    • AJoGPL
    • KURJ
    • AJLS
    • MyLOFT
    • Lexis Plus UK
    • Britannica Academic
    • Research Support Tools
    • Quick Resource Links
  • Login
Advanced
  • Author
  • Arif Abdillah
Showing 1 - 4 results of 4 for search 'Arif Abdillah', query time: 0.01s Refine Results
  1. 1
    Clinical Effectiveness, Safety and Tolerability of Amlodipine/Valsartan in Hypertensive Patients: the Indonesian Subset of the EXCITE Study

    Clinical Effectiveness, Safety and Tolerability of Amlodipine/Valsartan in Hypertensive Patients: the Indonesian Subset of the EXCITE Study by Arini Setiawati, Harmani Kalim, Arif Abdillah

    Published 2015-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Clinical Effectiveness, Safety and Tolerability of Amlodipine/Valsartan in Hypertensive Patients: the Indonesian Subset of the EXCITE Study

    Clinical Effectiveness, Safety and Tolerability of Amlodipine/Valsartan in Hypertensive Patients: the Indonesian Subset of the EXCITE Study by Arini Setiawati, Harmani Kalim, Arif Abdillah

    Published 2015-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL)

    CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL) by Dody Ranuhardy, Evlina Suzanna, Resti M Sari, Dwi W Hadisantoso, Rizka Andalucia, Arif Abdillah

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL)

    CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL) by Dody Ranuhardy, Evlina Suzanna, Resti M Sari, Dwi W Hadisantoso, Rizka Andalucia, Arif Abdillah

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs